Health Care Software Products company

1. Project Pheme
Jan. 2015
Preliminary and Confidential
For discussion purposes only
PHEMESOFT
Software That Matters

2. Company :
Vision and Mission
Project Pheme
O
We put "Individual" at the Hub of all our perspective thinking and
actions and processes. This results in all our products and
solutions creating benefit to an individual. This in turn will change
the way the industry functions in the long run creating a lasting
"Customer Benefit" to the individual as well as the industry that
serve the individual. Hence we call ourselves as "Positive Social
Impact Company".
We create innovative products and solutions and constantly keep
up the tempo of innovation in our efforts. We understand every
changing and growing needs of technology and marry such changes
with the needs of the human society. By creating an environment
of constant touch with the users, Continuity of Innovation become
imperative for us.
We believe and always strive hard in creating 3 C's - Customer
Benefit, Continuity of Innovation and Cost Savings.
Focusing on developing innovative software products in niche
technology areas particularly in CAMS ( Cloud, Analytics, Mobility
and Social Technology )
PHEMESOFT
SoftwareThat Matters
Vision
We shall create " Positive Social Impact " through a differentiated
perspective thinking, innovativeactions, products and solutionsof
longevity.
Mission
-Create innovativesoftware and hardware productsand solutions
​- Focus on 3 C's - "Customer Benefit, Continuityof InnovationandCost
Savings"
- Put "I- Individual" at the Hub of all perspective thinking

3. The problem / challenge
• Current Market challenges:
– The main cause of the explosion in health costs is the inefficiency of isolated
and non-integrated channels of information.
– shaped by vested interests of single players in the health market.
– With a fast-growing population, the inefficiency and ‘frictional loss’ of this
model of data exchange feeding today’s care solutions is growing out of all
proportion.
– confusion and mistruston the part of patients, who are excluded from the
process and forced into a passive role
– Flow of data selective and non-transparent
– non-affordability and non-accessibility of healthcare for many.
Hard facts Project Pheme
O

4. Proposed Solution
• Health Care Software Products on an end to end Platform for the Industry
creating a value chain for all the players driven by the Individual focus and
perspective.
• The Centrifugal point of the solution model is an INDIVIDUAL( i )
• We are building various software and hardware products to serve the ‘ i ‘ most
effectively.
• The total healthcare solution being built will address:
– Individual needs,
– Integration,
– Information management,
– Ease of operations,
– Ease of service,
– Cost leverage,
– Sharing,
– Creating an eco-system
• Benefit - that can benefit the individual while benefiting the entire eco-system to
ChallengeMitigation Project Pheme

5. Unique Selling Policy!
i
Pharma
manufacturer
Related
Persons
Insurance &
TPAs Medical
professionals
Hospitals,
Clinics &
Labs
HealthCare
workers
Pharma
Distributors
and Retailers
Government
& Policy
Bodies
Medical
Research
Our Health Care Solutions:
•The Center point of our solution
model is - “INDIVIDUAL”
•We are developing software and
hardware products and solutions to
serve the ‘ i ‘ most effectively.
•The total healthcare solution being
developed will address the individual
needs, integration, information
management, ease of operations &
services, cost leverage and sharing
platform there by creating an eco-
system that can benefit the individual
as well as entire industry.
Project Pheme

6. Organisation Structure
Board of Directors
Nagesh S Belur
Managing Director
DR. Radheshyam Naik
Director- Mentor,
Advisor- Health Care
Guruprasad Kini
Director –
Product
Development &
Innovation
Satish Chandra
Director –
Marketing &
Sales)
K S Rangaraj
Director –HR,
Compliance &
Admin
Fmr Thought
Leader in IBM,
with a rich
experience of
over 20 years
Project Pheme

7. Key Management Personnel
SRI NAGESH S BELUR
Managing Director
Sri.Nagesh S Belur, Promoter of this company, and an ex-IBMer, is a techno-functional leader
with high degree of innovative thinking and deep intent of social development and
compassion. He has 35+ years of overall experience and donned various caps as Software
Developer, Solutions Architect, Researcher, Technology Delivery Leader, Hiring Manager,
Mentor, Banker, Turn-aroundspecialist etc.
He has global exposure in software industry working with customers and teams across almost
all continents in both product companies as well as service companies. He has been a global
leader in IBM global delivery and an architect of products in IBM software labs and Oracle
FSS. He has set up Center of Excellence for various products both in IBM and Capgemini.
He has ideated the products of this company and with a sole purpose of providing Positive
Social Impact creating software products in the Healthcare domain using the niche and
emerging technology of Cloud, Mobility, Bid Data Analytics and Social platforms, he has
incubatedthis company. He holds the position of Managing Director on the Board.
Project Pheme

8. Key Management
SRI RADHESHYAM NAIK
Director – Mentor, Advisor – HealthCare
DR. Radheshyam Naik is an accomplished and highly qualified expert
in Oncology and stem Cell Transplantation. He has been a Member
of Ethics Committee for clinical trials at KMIO and also a member of
Scientific Committee for Clinical trials at HCG. He has to his credit
many publications in several medical journals of renown across the
globe. He has been involved in over 35 important Clinical trials either
completed or on-going as either Principal Investigator or as co-
investigator
SRI SATISH CHANDRA BIDARE
Director – Marketing & Sales
Sri Satish Chandra Bidare is a Business Leader with specific exposure
to Marketing services for over 38 years. As a CEO of Yuken India he
has all round experience of leading the company in its growth path.
He has extensive experience in growing customer base for products
and led the teams to a sales and marketing success across India and
global markets. He has worked for a long time with Japanese
companies, management, customers and employees whereby
imbibing the discipline, fineness and cost conscious approach in his
work. He has exposure to manufacturing best practices along with
marketing techniques.
SRI. GURUPRASAD KINI
Director - Product Development and Innovation
Sri. Guruprasad Kini is a technology leader with specific exposure to
software product development and project management over 14
years. Currently working at a leadership position in a Healthcare
Software Product Development company specializing in - Electronic
Health Record (EHR) design, Meaningful Use (ARRA MU) Stage II
certification consulting, Continuity of Care Document (CCD), HL7
Consolidated Clinical Document Architecture (CCDA)
implementation, Secure Messaging (DIRECT), HL7 Messaging 2.3.x
and 2.5.x, SNOMED-ICD9-ICD10 code families and translations the
Healthcare domain.
SRI K S RANGARAJ
Director – HR, Compliance & Admin
Sri K S Rangaraj is a leading Human Resources professional with
experience of over 31 years in HRM, personnel and administration.
Currently working as a Human Resource Head, he has had extensive
experience in organizational development, human resource
management, Industrial relations, personnel & administration
including statutory compliance, learning and development, social
compliance, facilities management and materials management. He
has hands-on experience in facilitating modern quality practices
including Quality Circle, Kaizen and TPM and has participated actively
in several international conferences in his fields of expertise.
Key Management Personnel Project Pheme

9. Global market - Segment & Size
The Asia-Pacific region’s health care spending is expected to grow at a rate of 7.1 percent from 2013-2017,10 as the rollout of
public health care systems, growing consumer wealth, and lifestyle changes continue to boost demand. India has expanded
its primary care policy priority and is expected to increase spending at an average rate of 17 percent a year, followed by
China at over 14 percent a year. Indonesia, Thailand, the Philippines, and Malaysia are also likely to see double-digit annual
growth as they expand their health insurancesystems.
Project Pheme
Global - Global & India Health Care Market Size

10. Financial Projections Project Pheme
O
Y1 Y2 Y3 Y4 Y5
Revenues 0 .15 20.76 154.38 394.08 864.68
Growth 0% 13683% 644% 155% 119%
GE 0.15 10.27 90.65 158.07 143.57
EBIDTA 0.08 4.38 103.72 255.58 516.24
NP 0.29 1.70 70.94 176.84 358.75
INRCrores
INR Crores
EBIDTA
Revenue
0.15
20.76
154.38
394.08
864.68
0.08 4.38
103.72
255.58
516.24
Year 1 Year 2 Year 3 Year 4 Year 5
0.02
0.75
4
6
10
0
2
4
6
8
10
12
Year 1 Year 2 Year 3 Year 4 Year 5
Number of users in Millions
Number of users in
Millions
0
50
100
150
200
250
300
350
400
450
Year
1
Year
2
Year
3
Year
4
Year
5
0.06 11.6
115.25
252
408
Number of hits in Millions
Number of hits in
Millions

11. Competition
Competition analysis for the Company Products
Project Pheme
O
 FIRST MOVER - For the First time in the Health Care Industry, the company is coming out with an end to end solution for the entire Industry.
The Vision of the company is completely driven by “Software with a Social Impact” which is unmatched in the market.
 A Scan of the market indicates that there are some small players and bit players in the marketwho are either playingthe:
 B2C- “Android” Game by developing Mobile Aps only to meet specific point requirements such as Doctor appointments, health record
management, drug price comparison or
 B2B - playing the “Smart app” game by providing inventory ordering, scheduling, invoice generation etc for retailers and hospitals.
These product “silos” are against the concept of “ individual “ driven Health care Platform that our companyis developing.
 Comprehensively, there is no ONE SINGLE COMPANY OR PRODUCT OR SOLUTION that operates in the space market space with similar
platform / products / solutions to be termed as Wholesome competitor.
Further, the scale with which the small and bit players are playing is nothingworthconsidering as competition
 Our Epidemico Product is the first of its kind and has high technology content as well as huge impact on various populations on a global
scale and such a product is not even dreamtof by any one till date
 Our Pill Book Product with all the other integrated products is first of its kind in the Health Care Industry which operates on a HUGE SCALE
and touch every health care player.
 These products will bring not only scale but also helps leverage the strength of all the health care players by a single platform of
coordinated Delivery, Research, Production, distribution and Care thereby brining huge amount of cost benefit as well as scale benefit to all
the participants.
 Our analytical platform based on the products will provide a non siloed actionable intelligence and information providing benefits to the
society in total and business in particular.
 Hence, we will have the first mover advantage in the Health Care Software Market.